Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/27242| Title: | Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML). | Authors: | Fleming S.;Loh J.B.E.;Walker P.;Avery S.;Patil S.;Spencer A.;Wei A. | Monash Health Department(s): | Haematology | Institution: | (Loh, Walker, Patil, Spencer, Wei, Fleming) Department of Haematology, Alfred Hospital, Melbourne, Australia (Walker) Peninsula Private Hospital, Melbourne, Australia (Walker) Department of Haematology, Peninsula Health, Melbourne, Australia (Avery) Department of Haematology, Cairns Base Hospital, Cairns, Australia (Patil, Spencer, Wei) The Australian Centre for Blood Diseases, Monash University, Melbourne, Australia (Fleming) Department of Haematology, Monash Health, Melbourne, Australia (Fleming) Department of Haematology, Northern Health, Melbourne, Australia (Fleming) Central Clinical School, Monash University, Melbourne, Australia | Issue Date: | 22-Feb-2021 | Copyright year: | 2021 | Publisher: | Taylor and Francis Ltd. | Place of publication: | United Kingdom | Publication information: | Leukemia and Lymphoma. 62 (2) (pp 489-491), 2021. Date of Publication: 2021. | Journal: | Leukemia and Lymphoma | DOI: | http://monash.idm.oclc.org/login?url= http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1080/10428194.2020.1832663 |
PubMed URL: | 33047641 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33047641] | ISSN: | 1042-8194 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/27242 | Type: | Letter | Subjects: | female gene mutation *graft recipient haploidentical transplantation human induction chemotherapy letter leukemia relapse leukemia remission male minimal residual disease monosomy 7 multiple cycle treatment myeloblast myelodysplastic syndrome pancytopenia/dt [Drug Therapy] priority journal real time reverse transcription polymerase chain reaction renal replacement therapy-dependent renal disease sibling donor transplantation conditioning unrelated donor cyclosporine/dt [Drug Therapy] cyclosporine/tm [Unexpected Outcome of Drug Treatment] cytarabine/dt [Drug Therapy] cytarabine/pv [Special Situation for Pharmacovigilance] DNA methyltransferase 3A/ec [Endogenous Compound] etoposide/dt [Drug Therapy] fludarabine idarubicin/dt [Drug Therapy] idarubicin/pv [Special Situation for Pharmacovigilance] melphalan *nucleophosmin/ec [Endogenous Compound] thiotepa thymocyte antibody/dt [Drug Therapy] venetoclax/dt [Drug Therapy] consolidation chemotherapy CD135 antigen/ec [Endogenous Compound] CD33 antigen/ec [Endogenous Compound] cyclophosphamide *acute myeloid leukemia/dt [Drug Therapy] adult aged allogeneic stem cell transplantation aplastic anemia/dt [Drug Therapy] bone marrow biopsy cancer chemotherapy *cancer patient case report chimera clinical article continuous infusion DNA methylation dysplasia continuous infusion DNA methylation dysplasia female gene mutation *graft recipient haploidentical transplantation human induction chemotherapy Letter leukemia relapse leukemia remission male minimal residual disease monosomy 7 multiple cycle treatment myeloblast myelodysplastic syndrome pancytopenia / drug therapy priority journal real time reverse transcription polymerase chain reaction aged sibling donor transplantation conditioning unrelated donor adult *acute myeloid leukemia / *drug therapy renal replacement therapy-dependent renal disease allogeneic stem cell transplantation aplastic anemia / drug therapy bone marrow biopsy cancer chemotherapy *cancer patient case report chimera clinical article consolidation chemotherapy |
Type of Clinical Study or Trial: | Case series or case report |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.